✦ LIBER ✦

Topotecan in second-line treatment of small cell lung cancer reduced toxicity with individualized therapy

✍ Scribed by Koschel, R; Huber, R.M; Gatzemeier, U; Gosse, H; von Pawel, J; Hruska, D; Mezger, J; Saal, J.G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of topotecan in treating small

✍ von Pawel, Joachim 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 661 KB

Emerging Role of Topotecan in First-Line

✍ F. Anthony Greco; John D. Hainsworth 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 165 KB

P-576 Phase II trial of weekly topotecan

✍ Greco, F. Anthony; Burris, Howard A.; Yardley, Denise Aysel; Hainsworth, John Da 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Pooled analysis of topotecan (T) in the

✍ Eckardt, J.; Depierre, A.; Ardizzoni, A.; Von Pawel, J.; Fields, S. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Topotecan–carboplatin–etoposide combinat

✍ Zarogoulidis, K.; Mylonaki, E.; Kakavelas, P.; Zarogoulidis, P.; Tsiouda, Th.; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Docetaxel in Second-Line Treatment of no

✍ Frank V. Fossella 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 142 KB